Приказ основних података о документу
The corona-virus disease 2019 pandemic compromised routine care for hypertension: a survey conducted among excellence centers of the European Society of Hypertension
dc.creator | Weber, Thomas | |
dc.creator | Januszewicz, Andrzej | |
dc.creator | Rosei, Enrico Agabiti | |
dc.creator | Tsioufis, Konstantinos | |
dc.creator | Okorie, Michael | |
dc.creator | Stergiou, George S. | |
dc.creator | Volpe, Massimo | |
dc.creator | Kreutz, Reinhold | |
dc.creator | Abraham, Gyorgy | |
dc.creator | Azizi, Michel | |
dc.creator | Barna, Istvan | |
dc.creator | Barroso, Weimar Kunz Sebba | |
dc.creator | Brguljan, Jana | |
dc.creator | Chapman, Neil | |
dc.creator | De, Backer, Tine | |
dc.creator | Dorobantu, Maria | |
dc.creator | Eckert, Siegfried | |
dc.creator | Gaciong, Zbigniew | |
dc.creator | Giannattasio, Cristina | |
dc.creator | Glover, Mark | |
dc.creator | Gottsaeter, Anders | |
dc.creator | Grassos, Charalampos | |
dc.creator | Jarai, Zoltan | |
dc.creator | Aguila, Fernando Jaen | |
dc.creator | Kahan, Thomas | |
dc.creator | Lopez-Sublet, Marilucy | |
dc.creator | Lović, Dragan | |
dc.creator | Lurbe, Empar | |
dc.creator | Makris, Thomas K. | |
dc.creator | Mallamaci, Francesca | |
dc.creator | Manolis, Athanasios J. | |
dc.creator | Marketou, Maria | |
dc.creator | Mazza, Alberto | |
dc.creator | Mediavilla, Juan Diego | |
dc.creator | Muiesan, Maria Lorenza | |
dc.creator | Muxfeldt, Elizabeth Silaid | |
dc.creator | Nasr, Edgar | |
dc.creator | Papadakis, Ioannis | |
dc.creator | Parounak, Zelveian | |
dc.creator | Obregon, Sebastian | |
dc.creator | Okorie, Michael | |
dc.creator | Oliveras, Anna | |
dc.creator | Pontremoli, Roberto | |
dc.creator | Raev, Dimitar | |
dc.creator | Rajkumar, Chakravarthi | |
dc.creator | Redon, Josep | |
dc.creator | Robles, Nicolas Roberto | |
dc.creator | Rump, Lars Christian | |
dc.creator | Sarzani, Riccardo | |
dc.creator | Sierra, Cristina | |
dc.creator | Sirenko, Yuriy | |
dc.creator | Stojanov, Vesna | |
dc.creator | Tikkanen, Ilkka | |
dc.creator | Vaclavik, Jan | |
dc.creator | Veglio, Franco | |
dc.creator | Viigimaa, Margus | |
dc.creator | Webb, David | |
dc.creator | Zebekakis, Pantelis | |
dc.creator | Zweiker, Robert | |
dc.date.accessioned | 2022-04-05T15:37:02Z | |
dc.date.available | 2022-04-05T15:37:02Z | |
dc.date.issued | 2021 | |
dc.identifier.issn | 0263-6352 | |
dc.identifier.uri | http://rimsi.imsi.bg.ac.rs/handle/123456789/1477 | |
dc.description.abstract | Background: The Covid-19 pandemic caused a shutdown of healthcare systems in many countries. We explored the impact on hypertension care in the Excellence Center (EC) network of the European Society of Hypertension. Methods: We conducted a 17-question electronic survey among ECs. Results: Overall, 52 ECs from 20 European and three non-European countries participated, providing hypertension service for a median of 1500 hypertensive patients per center per year. Eighty-five percent of the ECs reported a shutdown lasting for 9 weeks (range 0-16). The number of patients treated per week decreased by 90%: from a median of 50 (range 10-400) before the pandemic to a median of 5.0 (range 0-150) during the pandemic (P lt 0.0001). 60% of patients (range 0-100%) declared limited access to medical consultations. The majority of ECs (57%) could not provide 24-h ambulatory BP monitoring, whereas a median of 63% (range 0-100%) of the patients were regularly performing home BP monitoring. In the majority (75%) of the ECs, hypertension service returned to normal after the first wave of the pandemic. In 66% of the ECs, the physicians received many questions regarding the use of renin-angiotensin system (RAS) blockers. Stopping RAS-blocker therapy (in a few patients) either by patients or physicians was reported in 27 and 36.5% of the ECs. Conclusion: Patient care in hypertension ECs was compromised during the Covid-19-related shutdown. These data highlight the necessity to develop new strategies for hypertension care including virtual clinics to maintain services during challenging times. | en |
dc.publisher | Lippincott Williams & Wilkins, Philadelphia | |
dc.rights | restrictedAccess | |
dc.source | Journal of Hypertension | |
dc.subject | renin-angiotensin system inhibitors | en |
dc.subject | hypertension routine care | en |
dc.subject | Covid-19 | en |
dc.subject | blood pressure | en |
dc.title | The corona-virus disease 2019 pandemic compromised routine care for hypertension: a survey conducted among excellence centers of the European Society of Hypertension | en |
dc.type | article | |
dc.rights.license | ARR | |
dc.citation.epage | 195 | |
dc.citation.issue | 1 | |
dc.citation.other | 39(1): 190-195 | |
dc.citation.rank | M21~ | |
dc.citation.spage | 190 | |
dc.citation.volume | 39 | |
dc.identifier.doi | 10.1097/HJH.0000000000002703 | |
dc.identifier.pmid | 33273364 | |
dc.identifier.scopus | 2-s2.0-85097125175 | |
dc.identifier.wos | 000612182400024 | |
dc.type.version | publishedVersion |